Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and Effectiveness of Rivaroxaban Versus Warfarin Across GFR Levels in Atrial Fibrillation: A Population-Based Study in Australia and Canada.
Ha JT, Scaria A, Andrade J, Badve SV, Birks P, Bota SE, Campain A, Djurdjev O, Garg AX, Harel Z, Hemmelgarn B, Hockham C, James MT, Jardine MJ, Lam D, Levin A, McArthur E, Ravani P, Shao S, Sood MM, Tan Z, Tangri N, Whitlock R, Gallagher M, Jun M. Ha JT, et al. Among authors: hockham c. Kidney Med. 2023 May 16;5(7):100675. doi: 10.1016/j.xkme.2023.100675. eCollection 2023 Jul. Kidney Med. 2023. PMID: 37492112 Free PMC article.
Incidence and Associations of Chronic Kidney Disease in Community Participants With Diabetes: A 5-Year Prospective Analysis of the EXTEND45 Study.
Sukkar L, Kang A, Hockham C, Young T, Jun M, Foote C, Pecoits-Filho R, Neuen B, Rogers K, Pollock C, Cass A, Sullivan D, Wong G, Knight J, Peiris D, Gallagher M, Jardine M; EXTEND45 Study Steering Committee. Sukkar L, et al. Among authors: hockham c. Diabetes Care. 2020 May;43(5):982-990. doi: 10.2337/dc19-1803. Epub 2020 Mar 11. Diabetes Care. 2020. PMID: 32161053 Free PMC article.
EXamining ouTcomEs in chroNic Disease in the 45 and Up Study (the EXTEND45 Study): Protocol for an Australian Linked Cohort Study.
Foote C, Hockham C, Sukkar L, Campain A, Kang A, Young T, Cass A, Chow CK, Comino E, Gallagher M, Jan S, Knight J, Liu B, McNamara M, Peiris D, Pollock C, Sullivan D, Wong G, Zoungas S, Rogers K, Jun M, Jardine M. Foote C, et al. Among authors: hockham c. JMIR Res Protoc. 2020 Apr 14;9(4):e15646. doi: 10.2196/15646. JMIR Res Protoc. 2020. PMID: 32285803 Free PMC article.
Therapy Escalation Following an Elevated HbA1c in Adults Aged 45 Years and Older Living With Diabetes in Australia: A Real-World Observational Analysis.
Xie Y, Baker J, Young T, Jun M, Sukkar L, Campain A, Kang A, Cass A, Hu J, Peiris D, Pollock C, Wong G, Zoungas S, Rogers K, Jardine M, Hockham C; EXTEND45 Steering Committee. Xie Y, et al. Among authors: hockham c. Diabetes Care. 2020 Nov;43(11):e185-e187. doi: 10.2337/dc20-0269. Epub 2020 Sep 14. Diabetes Care. 2020. PMID: 32928956 No abstract available.
Prevalence, incidence and risk factors of diabetes in Australian adults aged ≥45 years: A cohort study using linked routinely-collected data.
Zhang H, Rogers K, Sukkar L, Jun M, Kang A, Young T, Campain A, Cass A, Chow CK, Comino E, Foote C, Gallagher M, Knight J, Liu B, Lung T, McNamara M, Peiris D, Pollock C, Sullivan D, Wong G, Zoungas S, Jardine M, Hockham C; EXTEND45 Steering Committee. Zhang H, et al. Among authors: hockham c. J Clin Transl Endocrinol. 2020 Nov 10;22:100240. doi: 10.1016/j.jcte.2020.100240. eCollection 2020 Dec. J Clin Transl Endocrinol. 2020. PMID: 33294382 Free PMC article.
Blood Pressure Effects of Canagliflozin and Clinical Outcomes in Type 2 Diabetes and Chronic Kidney Disease: Insights From the CREDENCE Trial.
Ye N, Jardine MJ, Oshima M, Hockham C, Heerspink HJL, Agarwal R, Bakris G, Schutte AE, Arnott C, Chang TI, Górriz JL, Cannon CP, Charytan DM, de Zeeuw D, Levin A, Mahaffey KW, Neal B, Pollock C, Wheeler DC, Luca Di Tanna G, Cheng H, Perkovic V, Neuen BL. Ye N, et al. Among authors: hockham c. Circulation. 2021 May 4;143(18):1735-1749. doi: 10.1161/CIRCULATIONAHA.120.048740. Epub 2021 Feb 8. Circulation. 2021. PMID: 33554616
Kidney, Cardiovascular, and Safety Outcomes of Canagliflozin according to Baseline Albuminuria: A CREDENCE Secondary Analysis.
Jardine M, Zhou Z, Lambers Heerspink HJ, Hockham C, Li Q, Agarwal R, Bakris GL, Cannon CP, Charytan DM, Greene T, Levin A, Li JW, Neuen BL, Neal B, Oh R, Oshima M, Pollock C, Wheeler DC, de Zeeuw D, Zhang H, Zinman B, Mahaffey KW, Perkovic V. Jardine M, et al. Among authors: hockham c. Clin J Am Soc Nephrol. 2021 Mar 8;16(3):384-395. doi: 10.2215/CJN.15260920. Epub 2021 Feb 22. Clin J Am Soc Nephrol. 2021. PMID: 33619120 Free PMC article. Clinical Trial.
Effects of canagliflozin compared with placebo on major adverse cardiovascular and kidney events in patient groups with different baseline levels of HbA1c, disease duration and treatment intensity: results from the CANVAS Program.
Young TK, Li JW, Kang A, Heerspink HJL, Hockham C, Arnott C, Neuen BL, Zoungas S, Mahaffey KW, Perkovic V, de Zeeuw D, Fulcher G, Neal B, Jardine M. Young TK, et al. Among authors: hockham c. Diabetologia. 2021 Nov;64(11):2402-2414. doi: 10.1007/s00125-021-05524-1. Epub 2021 Aug 26. Diabetologia. 2021. PMID: 34448033 Free PMC article. Clinical Trial.
Prevalence of chronic kidney disease in Asia: a systematic review and analysis.
Liyanage T, Toyama T, Hockham C, Ninomiya T, Perkovic V, Woodward M, Fukagawa M, Matsushita K, Praditpornsilpa K, Hooi LS, Iseki K, Lin MY, Stirnadel-Farrant HA, Jha V, Jun M. Liyanage T, et al. Among authors: hockham c. BMJ Glob Health. 2022 Jan;7(1):e007525. doi: 10.1136/bmjgh-2021-007525. BMJ Glob Health. 2022. PMID: 35078812 Free PMC article.
36 results